Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 137
Selected: 0
NCT IDTitle
NCT05759572Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT06180174Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
NCT04636008Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
NCT07370116Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy
NCT06366997Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
NCT04998760A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )
NCT06717009A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.
NCT06481566Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial
NCT05594095SNF Platform Study of HR+/ HER2-advanced Breast Cancer
NCT07425795Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer
NCT06550739Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
NCT06059261Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
NCT06317610Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
NCT03759275pMDT in Thoracic Surgery--------For the Baseline Investigation and Technical Preparation Stage
NCT05461664Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
NCT05793749Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy
NCT03001596Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
NCT05205200Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
NCT07209787SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT05473728Epidemiology Study and Risk Factor Analysis on Chronic Post-surgical Pain After Video-assisted Thoracic Surgery
NCT06709885HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
NCT04542356Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer
NCT04555226The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
NCT03778268Sentinel Lymph Node Mapping In Cervical Cancer
NCT05779111A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer
NCT0656323222G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions
NCT05351346Genotype-guided Treatment in DLBCL
NCT05044871Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer
NCT05213884The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC
NCT05907447A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT04303247CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL
NCT06060080Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma
NCT01470495Combined Treatment of RFA and Sorafenib on Recurrent HCC
NCT06026995Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
NCT04516616Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT04276532Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus
NCT07248696Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial
NCT03286348Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer
NCT05290961The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening
NCT06055166A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors
NCT06556953Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients
NCT04409860The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
NCT06591078Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer
NCT05401162Chemotherapy Supported by Autologous Hematopoietic Stem Cells
NCT04905550Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC
NCT06507683Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
NCT04733820Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
NCT05786989Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
NCT06612814PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer